Clinical Utility of Switching to Insulin Degludec from Other Basal Insulins in Patients with Type 1 or 2 Diabetes

被引：0
|
作者：
Baran, O. [1 ,2 ]
Dersch-Mills, D. [1 ]
Bakal, J. [3 ]
Arbo, T. [1 ]
Hnatiuk, M. [1 ]
Roedler, R. [1 ]
机构：
[1] Alberta Hlth Serv, Serv Pharm, Calgary, AB, Canada
[2] Saskatchewan Hlth Author, Serv Pharm, Regina, SK, Canada
[3] Alberta Hlth Serv, Prov Res Data Serv, Edmonton, AB, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2021年 / 74卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [41] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    [J]. DIABETES, 2014, 63 : A232 - A232
  • [42] REAL LIFE DATA DEMONSTRATE SIGNIFICANT REDUCTIONS IN HBA1C IN T2DM PATIENTS SWITCHING FROM OTHER INSULINS TO INSULIN DEGLUDEC
    Cohen, Melzer C.
    Thorsted, B. L.
    Wolden, M. L.
    Chodick, G.
    Karasik, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A666 - A666
  • [43] Insulin degludec: a novel ultra-long-acting basal insulin for use in Type 1 and 2 diabetes
    Meneghini, Luigi F.
    Miranda-Palma, Bresta
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 9 - 14
  • [44] Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
    Tosaka, Yuka
    Kanazawa, Akio
    Ikeda, Fuki
    Iida, Mayu
    Sato, Junko
    Matsumoto, Kazuhisa
    Uchida, Toyoyoshi
    Tamura, Yoshifumi
    Ogihara, Takeshi
    Mita, Tomoya
    Shimizu, Tomoaki
    Goto, Hiromasa
    Ohmura, Chie
    Fujitani, Yoshio
    Watada, Hirotaka
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [45] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
    Luedemann, J.
    Merker, L.
    Milek, K.
    Kaiser, M.
    Wilhelm, B.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
  • [46] Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
    Ying Zhang
    Yi-juan Xie
    Dong-dong Meng
    Hao-hang Zhang
    Hui Chen
    En Liu
    [J]. Diabetology & Metabolic Syndrome, 6
  • [47] Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
    Zhang, Ying
    Xie, Yi-juan
    Meng, Dong-dong
    Zhang, Hao-hang
    Chen, Hui
    Liu, En
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [48] Efficacy and Safety of Switching from Basal Insulin to Sitagliptin in Japanese Type 2 Diabetes Patients
    Harashima, S. -I.
    Tanaka, D.
    Yamane, S.
    Ogura, M.
    Fujita, Y.
    Murata, Y.
    Seike, M.
    Koizumi, T.
    Aono, M.
    Wang, Y.
    Inagaki, N.
    [J]. HORMONE AND METABOLIC RESEARCH, 2013, 45 (03) : 231 - 238
  • [49] EFFICACY OF INSULIN DEGLUDEC AFTER SWITCHING FROM INSULIN GLARGINE OR INSULIN DETEMIR IN YOUNG PERSONS WITH TYPE 1 DIABETES
    Urakami, T.
    Kuwabara, R.
    Habu, M.
    Okuno, M.
    Suzuki, J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S235 - S236
  • [50] Cost-effectiveness analysis of insulin degludec/liraglutide (IDegLira) vs other basal insulin intensification strategies in Type 2 diabetes patients uncontrolled on basal insulin in a UK setting
    Davies, M.
    McEwan, P.
    Glah, D.
    Chubb, B.
    Konidaris, G.
    Iversen, P.
    [J]. DIABETIC MEDICINE, 2016, 33 : 155 - 155
12345